Full-Time
Business Unit Manager
Supply Resilience
BioPhorum
51-200 employees
Membership-based forums for biopharma and devices
No salary listed
London, UK
Remote
Annual travel: at least two UK trips and two international trips.
 Business & Strategy (2) |
|---|
| , |
- Proven experience in a senior commercial or strategic leadership role within life sciences or a related sector.
- Track record of driving strategy, adding client value, and delivering revenue growth.
- Strong client management skills, able to build and sustain senior relationships.
- Data-driven, numerate, and proficient in MS Office (intermediate–advanced).
- Excellent written and spoken English, with the ability to adapt communication to different audiences.
- Strategic problem solving and decision-making with commercial awareness.
- Operational rigor and process discipline, with a focus on continuous improvement.
- Exceptional collaboration and communication skills across internal teams and external stakeholders.
- Inspiring leadership, capable of motivating teams and fostering professional development.
- Proactive, curious, and commercially aware.
- Structured thinker with attention to detail and ability to deliver to deadlines.
- Collaborative and team-oriented, with a hands-on, solution-focused approach.
- Comfortable operating in a fast-paced, dynamic environment.
- Occasional travel: at least two trips within the United Kingdom and two international trips annually.
- Home-based role with occasional travel.
- Lead and motivate your Phorum team, ensuring clear objectives, development support, and performance excellence.
- Develop and execute the Phorum business plan, ensuring tangible member outcomes and measurable ROI.
- Build and maintain strategic relationships with L1 and L2 clients to support insights, retention, and industry impact.
- Oversee the delivery of high-quality virtual and in-person meetings, workshops, and events.
- Identify opportunities for thought leadership, industry influence, and cross-Phorum collaboration.
- Manage Phorum budgets, ensuring costs, resources, and events are aligned with financial and growth targets.
- Monitor KPIs, including NPS, eNPS, member retention, profitability, and thought leadership outputs.
BioPhorum is a B2B membership organization that enables collaboration across global biopharmaceutical and medical device industries. It provides a non-competitive space where leaders and experts tackle shared challenges, define best practices, and advance projects through focused forums called Phorums. Members from license holders, manufacturers, CDMOs, and suppliers work on industry-wide initiatives to improve operations, reduce costs, and streamline regulatory processes, plus tools like the Digital Plant Maturity Model (DPMM) to guide digital transformation. Its goal is to accelerate progress in biopharma and medical device manufacturing by sharing knowledge, setting industry-wide practices, and improving efficiency and regulatory readiness.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2008
Your Connections
People at BioPhorum who can refer or advise you
Simplify's Take
What believers are saying
- Strategic Advisory Board with Pfizer, GSK, Eli Lilly executives accelerates adoption of BioPhorum standards.
- Acquisitions of PharmaX, Inspired Pharma, Brookwood Global expand training and digital services by May 2026.
- Rx-360 joint audits with BSI standardize SUS supplier quality, enabling scalable licensing revenue.
What critics are saying
- EMA Joint Audit Programme commoditizes BioPhorum audits, eroding demand within 12-18 months.
- Rapid 2025-2026 acquisitions dilute core membership focus, causing integration failures in 6-12 months.
- Members defect as BioPhorum sells consulting via acquired firms, perceiving bias within 12-24 months.
What makes BioPhorum unique
- BioPhorum operates 11 Phorums directing over 100 workstreams with 7500 experts since 2008.
- BioPhorum facilitates pre-competitive collaboration among biopharma leaders and suppliers in safe spaces.
- BioPhorum influences regulatory environments through outputs like USP <665> roadmaps and HCP databases.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
BioPhorum, a pharmaceutical industry collaborative network, has announced the formation of its inaugural Strategic Advisory Board comprising 14 senior executives from major pharmaceutical companies. The board will provide executive guidance on critical industry challenges including global regulation, new technology and supply chain resilience. Members include executives from Pfizer, GSK, Eli Lilly, Amgen, Sanofi, Merck, SK Pharmteco, Fujifilm BioTechnologies, eXmoor, Sartorius, UCB and Cytiva. The board will serve as a forum for strategic dialogue on pressing industry-wide challenges and opportunities. BioPhorum CEO Deborah Kobewka described the board's launch as "a defining milestone", noting that executive-led direction is crucial as the industry navigates volatility and a challenging global investment landscape. The board aims to help members turn market complexity into a shared roadmap for sustainable growth.
Media Release 17 December 2025 BioPhorum acquires Inspired Pharma to enhance its training and support for pharmaceutical professionals worldwide Strategic acquisition strengthens BioPhorum’s ability to deliver insight, expertise, and practical solutions to its global membership and life sciences client community across the pharmaceutical value chain BioPhorum is pleased to announce the acquisition of Inspired Pharma, a leading provider of specialist training for the...
19 May 2025London, UKBioPhorum, the global organisation accelerating collaboration between biopharmaceutical and medical device industry leaders, is pleased to announce the appointment of Dr. Uwe Buecheler, as Non-Executive Director (NED) to its Board of Directors, effective May 19, 2025.Dr. Buecheler brings a wealth of experience and expertise in the biopharmaceutical industry, having held various leadership roles in development operations, strategic planning, and innovation. He has overseen more than 30 biologics launches, including several top global biopharmaceuticals and has held senior roles in regulatory affairs, CMC development, biosafety, quality, CDMO business and operations.Dr. Buecheler led the expansion of Boehringer Ingelheim's Global Operations Network in the US and China and pioneered the first Biologics MAH approval in Shanghai. He also contributed to major expansion projects in aseptic processing, microbial manufacturing, and large-scale mammalian cell culture operations
BioPhorum acquires training organisation Brookwood Global.
BioPhorum has acquired UK-based training provider Brookwood Global. This acquisition aims to integrate Brookwood's digital training expertise with BioPhorum's biopharmaceutical and life sciences knowledge, creating growth opportunities for both organizations. BioPhorum CEO Deborah Kobewka highlighted that this partnership will help expand BioPhorum's services and develop practical training resources for its members.